High Energy Physics - Theory
[Submitted on 19 Apr 1996 (v1), last revised 1 Aug 2000 (this version, v2)]
Title:A New Description of the Superstring
View PDFAbstract: This is a review of the new manifestly spacetime-supersymmetric description of the superstring. The new description contains N=2 worldsheet supersymmetry, and is related by a field redefinition to the standard RNS description. It is especially convenient for four-dimensional compactifications since SO(3,1) super-Poincaré invariance can be made manifest. Parts of this work have been done in collaboration with Warren Siegel and Cumrun Vafa.
This review is based on lectures given at the VIII J.A. Swieca summer school and should be easily accesible to anyone familiar with the RNS superstring description.
Submission history
From: Nathan Jacob Berkovits [view email][v1] Fri, 19 Apr 1996 23:33:46 UTC (21 KB)
[v2] Tue, 1 Aug 2000 20:44:17 UTC (21 KB)
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
Connected Papers (What is Connected Papers?)
CORE Recommender (What is CORE?)
IArxiv Recommender
(What is IArxiv?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.